Academic Uptake of Steritas STOX Suite Expands Across Trials and Institutions
Academic institutions worldwide are increasingly adopting the clinical outcome assessments (COA) of steroid-toxicity that make up the STOX® Suite from Steritas. To date, 26 academic licenses are in ...
In Conversation With… Lori McLeod, PhD
“Behind every data point is a patient story - and it’s the responsibility of healthcare researchers and practitioners to listen, measure, and respond.” As Vice President of Patient-Centered Outcomes ...
Designing Trials That Capture What Matters: Efficacy, Safety, and Steroid-toxicity
Despite decades of widespread use, steroids are facing a growing backlash. Leading researchers and sponsors are aligning on a new imperative: quantify the harm. A flurry of guidance, tools, and ...
In Conversation With… Professor Ailsa Hart
“We have to make the case that avoiding steroids isn’t just about following guidelines - it’s about protecting the long-term health of our patients.” Steroids remain a cornerstone of inflammatory ...
Measuring What Matters: Steroid-toxicity and Patient Outcomes
Ten years ago, two clinical researchers walked into a bar and, over a beer, asked themselves whether the direct measurement of steroid-toxicity would ever be possible. Today, Steritas, in licensing ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
